Laboratory

NOBLE PACIFIC, CALIFORNIA'S PREMIERE PESTICIDE-FREE CANNABIS OIL AND DISTILLATE MANUFACTURER, SETS A NEW STANDARD TO CORRECT LEGAL WEED'S "DIRTY SECRET"

Retrieved on: 
Tuesday, July 16, 2024

( LA Times ) Premiere oil and distillate manufacturer Noble Pacific's 100% pesticide-free, safe and "clean" oil can solve these widespread quality issues and set a new standard for the industry.

Key Points: 
  • ( LA Times ) Premiere oil and distillate manufacturer Noble Pacific's 100% pesticide-free, safe and "clean" oil can solve these widespread quality issues and set a new standard for the industry.
  • Born in response to the plethora of reliability issues with fellow cannabis oil and distillate manufacturers, Noble Pacific prioritizes transparency, integrity, analytical accuracy, and social responsibility to deliver a superior experience in both ethos and operation.
  • They produce premium grades of distillate that are rigorously sampled and dual-tested by California's toughest 3rd-Party licensed laboratories.
  • For more information on Noble Pacific, see their website for details on the modern standard for cannabis distillate oil throughout the industry.

JEAN MARTIN INC. APPOINTS MICHAEL CHING AS STRATEGY ADVISOR TO THE CEO AND BOARD MEMBER

Retrieved on: 
Tuesday, July 16, 2024

NEW YORK, July 16, 2024 /PRNewswire/ -- Jean Martin Inc. (JMI), a global technology, research, and analytics firm, announced the appointment of Michael Ching as Strategy Advisor to the CEO and Board Member, further strengthening its core leadership team.

Key Points: 
  • NEW YORK, July 16, 2024 /PRNewswire/ -- Jean Martin Inc. (JMI), a global technology, research, and analytics firm, announced the appointment of Michael Ching as Strategy Advisor to the CEO and Board Member, further strengthening its core leadership team.
  • Recently he was the Global Head of Investment Research at Evalueserve and was responsible for steering their financial practice for AI/ML initiatives.
  • "We are excited to welcome Michael to our Board and Executive Team," said Shawn Kumar, CEO of JMI.
  • JMI anticipates that Michael's appointment to the Board and as Strategy Advisor to the CEO will reinforce its commitment to delivering differentiated value to clients and stakeholders.

KYOCERA AVX Launches 20 New KAM Series Automotive MLCCs

Retrieved on: 
Tuesday, July 16, 2024

FOUNTAIN INN, S.C., July 16, 2024 /PRNewswire/ -- KYOCERA AVX, a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future, has expanded its line of KAM Series automotive MLCCs with the addition of 20 new components.

Key Points: 
  • FOUNTAIN INN, S.C., July 16, 2024 /PRNewswire/ -- KYOCERA AVX , a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future, has expanded its line of KAM Series automotive MLCCs with the addition of 20 new components.
  • KAM Series automotive MLCCs are designed, manufactured, and tested to ensure that they meet the high quality and reliability standards of automotive industry applications.
  • "KYOCERA AVX has been a trusted supplier of automotive MLCCs for several decades and is very proud to introduce the new small-case-size, high-capacitance-value, wide-voltage-range, and AEC-Q200-qualified KAM Series automotive MLCCs to market," said Kensuke Ikeda, Senior Manager – MLCC Development, KYOCERA Corporation.
  • For more information about KYOCERA AVX's new KAM Series automotive MLCCs, please visit https://www.kyocera-avx.com/products/ceramic-capacitors/surface-mount/au... .

Ventus Therapeutics Significantly Expands its Presence in Montreal, Canada with Opening of a New Laboratory and Office Facility

Retrieved on: 
Tuesday, July 16, 2024

Ventus Therapeutics , a clinical-stage biopharmaceutical company utilizing its proprietary, machine learning-enabled, computational chemistry platform, ReSOLVE™, and its deep protein science expertise to develop differentiated small molecule therapeutics, today announced the opening of a new laboratory and office facility in Montreal, Canada.

Key Points: 
  • Ventus Therapeutics , a clinical-stage biopharmaceutical company utilizing its proprietary, machine learning-enabled, computational chemistry platform, ReSOLVE™, and its deep protein science expertise to develop differentiated small molecule therapeutics, today announced the opening of a new laboratory and office facility in Montreal, Canada.
  • The new 24,000-square-foot state-of-the-art facility more than doubles Ventus’ laboratory and office space in Montreal and allows Ventus to strategically expand its R&D capacity to enable the continued growth of its pipeline and further development of its proprietary ReSOLVE™ platform.
  • “This new facility expands our presence in Montreal and augments our existing facilities in Waltham, MA,” said Marcelo Bigal, M.D., Ph.D., President and CEO of Ventus.
  • This new facility represents the second phase of Ventus’ global expansion and augments Ventus’ 13,000-square-foot facility in Waltham, Massachusetts, which houses Ventus’ corporate offices and laboratories for its structural biology, biochemistry, protein sciences, molecular biology, and cellular biology teams.

Silicon Labs Announces Second Quarter 2024 Earnings Webcast

Retrieved on: 
Monday, July 15, 2024

AUSTIN, Texas, July 15, 2024 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced that it plans to release second quarter 2024 financial results on Wednesday, July 24, 2024.

Key Points: 
  • AUSTIN, Texas, July 15, 2024 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced that it plans to release second quarter 2024 financial results on Wednesday, July 24, 2024.
  • An earnings conference call will follow the release at 7:30 a.m. Central Time.
  • Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world.
  • Silabs.com
    Note to editors: Silicon Labs, Silicon Laboratories, the "S" symbol, the Silicon Laboratories logo and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

Cross Company to open calibration lab in the metro Atlanta area

Retrieved on: 
Monday, July 15, 2024

GREENSBORO, N.C., July 15, 2024 /PRNewswire-PRWeb/ -- Cross Company, a 100% employee-owned industrial solutions company that is innovating industry, one customer at a time, announced today that their Precision Measurement group has opened a new calibration laboratory in the metro Atlanta area of Georgia.

Key Points: 
  • Cross Company is opening its 19th calibration lab in the metro Atlanta area to provide world class service and technical expertise to its customers in northern Georgia.
  • GREENSBORO, N.C., July 15, 2024 /PRNewswire-PRWeb/ -- Cross Company, a 100% employee-owned industrial solutions company that is innovating industry, one customer at a time, announced today that their Precision Measurement group has opened a new calibration laboratory in the metro Atlanta area of Georgia.
  • Prior to opening the new lab, customers in this area were served by Cross Company's Chattanooga, TN and Greenville, SC labs.
  • King continued that, "Cross has had a presence in Atlanta for years, both account managers and brick and mortar locations, but this is the first for a Precision Measurement calibration lab."

Global Access Doors & Panels Market Outlook & Forecast 2024-2029, with Key Vendor Profiles for Activar Construction Products Group, Acudor Products, Elmdor, Karp Associates and Williams Brothers - ResearchAndMarkets.com

Retrieved on: 
Monday, July 15, 2024

The global access doors and panels market exhibits a notable level of fragmentation, with numerous participants operating on both local and international scales.

Key Points: 
  • The global access doors and panels market exhibits a notable level of fragmentation, with numerous participants operating on both local and international scales.
  • Major global access doors and panels market vendors encompass Activar Construction Products Group, Acudor Products, Elmdor, Karp Associates, Williams Brothers Corporation of America, and others.
  • The growth of commercial spaces such as shopping malls, retail areas, and offices is expected to support the growth of the global access doors and panels market.
  • The global access doors and panels market segmentation by type is divided into general-purpose, fire-rated, drywall, and security.

American Public University System and the Policy Studies Organization to Co-Host Free Virtual Conference on AI and the Future of Education on Aug 1-2

Retrieved on: 
Monday, July 15, 2024

The conference provides an opportunity to focus on AI's disruptive, transformative, and evolving role in higher education.

Key Points: 
  • The conference provides an opportunity to focus on AI's disruptive, transformative, and evolving role in higher education.
  • Presenters will share current findings, identify challenges, and seek solutions through rich discussions and networking, to help reimagine the future of education.
  • "We owe it to our current and future students to fully explore these possibilities.
  • Topics slated include upcoming AI innovations for education, the ethical challenges of AI and increasing access to AI through curriculum design, teaching and learning, and open educational resources.

Othram Achieves ISO/IEC 17025:2017 Accreditation Through ANAB for Massively Parallel Sequencing

Retrieved on: 
Monday, July 15, 2024

THE WOODLANDS, Texas, July 15, 2024 /PRNewswire-PRWeb/ -- Othram, the leading forensic sequencing laboratory for law enforcement, is pleased to announce that their forensic laboratory has been accredited by the ANSI National Accreditation Board to the ISO/IEC 17025:2017 standards for Forensic Testing and Calibration Laboratories, for Single-Nucleotide Polymorphism (SNP) testing utilizing Massively Parallel Sequencing (MPS).

Key Points: 
  • Othram's forensic DNA testing laboratory has been accredited by the ANSI National Accreditation Board to the ISO/IEC 17025:2017 standards for Forensic Testing and Calibration Laboratories.
  • THE WOODLANDS, Texas, July 15, 2024 /PRNewswire-PRWeb/ -- Othram, the leading forensic sequencing laboratory for law enforcement, is pleased to announce that their forensic laboratory has been accredited by the ANSI National Accreditation Board to the ISO/IEC 17025:2017 standards for Forensic Testing and Calibration Laboratories, for Single-Nucleotide Polymorphism (SNP) testing utilizing Massively Parallel Sequencing (MPS).
  • Developed by Othram, Forensic-Grade Genome Sequencing® has been instrumental in solving numerous active and cold cases for local, state, and federal agencies across the United States and internationally.
  • "We are thrilled to offer best-in-class forensic DNA testing with the quality system that stakeholders seek," said Othram CEO David Mittelman.

Joint Statement - Detection of MSX in Bedeque Bay, Prince Edward Island

Retrieved on: 
Saturday, July 13, 2024

OTTAWA, ON, July 13, 2024 /CNW/ - The Canadian Food Inspection Agency (CFIA) has confirmed the presence of multinuclear sphere X (MSX) caused by Haplosporidium nelsoni in wild oyster samples collected in Bedeque Bay, Prince Edward Island (PEI).

Key Points: 
  • OTTAWA, ON, July 13, 2024 /CNW/ - The Canadian Food Inspection Agency (CFIA) has confirmed the presence of multinuclear sphere X (MSX) caused by Haplosporidium nelsoni in wild oyster samples collected in Bedeque Bay, Prince Edward Island (PEI).
  • These actions are part of the Government of Canada's One Health approach to prepare for, detect, and manage animal diseases.
  • Haplosporidium nelsoni causes multinuclear sphere X (MSX) disease in cultured and wild American oysters, specifically Crassostrea virginica.
  • Ongoing federal and provincial control and detection measures for MSX span the continuum from monitoring/surveillance and risk assessment, to laboratory capacity, updated guidance and communications, and science coordination.